Ventus Therapeutics US Inc. has divulged NLRP3 inflammasome inhibitors reported to be useful for the treatment of cancer, metabolic diseases, autoimmune diseases, and liver, renal, respiratory, ...
In a paper titled "Arachidonic acid inhibition of the NLRP3 inflammasome is a mechanism to explain the anti-inflammatory effects of fasting," published in Cell Reports, the team describes how fasting ...
Merriman’s research interests also include outcomes in gout, especially severity and drug response. He also applies genetic epidemiological techniques to understanding the causal relationships in gout ...